| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA5252437 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus aureus | 34 | organism-based format | Scientific Literature | ||
| 2. | ALA5252438 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus aureus | 34 | organism-based format | Scientific Literature | ||
| 3. | ALA5252439 | F | Antibacterial activity against Methicillin-resistant Staphylococcus epidermidis ATCC 51625 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus epidermidis | 34 | organism-based format | Scientific Literature | ||
| 4. | ALA5252440 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus aureus | 34 | organism-based format | Scientific Literature | ||
| 5. | ALA5252441 | F | Antibacterial activity against Methicillin-sensitive Staphylococcus epidermidis ATCC 12228 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus epidermidis | 34 | organism-based format | Scientific Literature | ||
| 6. | ALA5252442 | F | Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus aureus | 34 | organism-based format | Scientific Literature | ||
| 7. | ALA5252443 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial growth inhibition at 1 to 2 times MIC measured upto 24 hrs by time kill assay | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
| 8. | ALA5252444 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial colony inhibition at 1 to 2 times MIC measured upto 24 hrs by time kill assay | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
| 9. | ALA5252445 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial bactericidal effect at 4 times MIC measured at 12 hrs by time kill assay | Staphylococcus aureus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA5252446 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial bactericidal effect at 1 to 2 times MIC measured upto 24 hrs by time kill assay | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
| 11. | ALA5252447 | F | Anticancer activity against human HepG2 cells assessed as cell survival upto 40 ug/ml measured upto 72 hrs by MTT assay relative to control | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 12. | ALA5252448 | F | Anticancer activity against human HeLa cells assessed as cell survival upto 40 ug/ml measured upto 72 hrs by MTT assay relative to control | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 13. | ALA5252449 | F | Anticancer activity against human A549 cells assessed as cell survival upto 40 ug/ml measured upto 72 hrs by MTT assay relative to control | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA5252450 | T | Cytotoxicity against mouse RAW264.7 cells assessed as cell survival upto 40 ug/ml measured upto 72 hrs by MTT assay relative to control | Mus musculus | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA5252452 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in IP dosed ICR mouse assessed as reduction in inflammation by hematoxylin and eosin staining based light microscopic analysis | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
| 16. | ALA5252453 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in ICR mouse assessed as number of inflammatory cells at 20 mg/kg, IP by hematoxylin and eosin staining based light microscopic analysis | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
| 17. | ALA5252454 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in ICR mouse assessed as number of inflammatory cells at 40 mg/kg, IP by hematoxylin and eosin staining based light microscopic analysis | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
| 18. | ALA5252455 | F | Invivo antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in ICR mouse skin infection model assessed as wound healing measured after 2 to 3 days | Staphylococcus aureus | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA5252456 | F | Invivo antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in mouse skin infection model assessed as wound healing treated as ointment at 3 % administered every 24 hrs and measured after 5 days | Staphylococcus aureus | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA5252458 | F | Invivo antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in mouse skin infection model assessed as decrease in TNF-alpha level treated as ointment at 1 % administered every 24 hrs and measured after 5 days by ELISA assay | Staphylococcus aureus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!